Confidential
Chief Medical Officer (CMO)
About the Company
Excelling biotechnology (BioTech) company
Industry Biotechnology
Type Privately Held
About the Role
The Company is in search of a Chief Medical Officer (CMO) to spearhead the clinical and regulatory strategy for its innovative pipeline, with a focus on antibody-drug conjugates in cancer therapeutics. The successful candidate will be responsible for defining and overseeing the clinical development strategy, leading all IND, CTA, and regulatory filings, and directing Phase I-III clinical trials to ensure scientific and operational excellence. This role also involves close collaboration with R&D and translational medicine teams to optimize biomarker-driven trial design, as well as representing the company at various industry events. The CMO will play a key role in partnering with business development and commercial teams on strategic partnerships and future market planning.
Applicants for the CMO position at the company should hold an MD or MD/PhD with a minimum of 10 years' experience in clinical development, particularly in the field of oncology. A strong background in oncology drug development, including experience with bispecifics, T-cell engagers, and immune modulators, is essential. The ideal candidate will have a proven track record of advancing oncology assets from early-phase trials through regulatory approval and possess strong experience in regulatory interactions with global health authorities. The role requires the ability to thrive in a high-growth, VC-backed biotech environment and demands a leader who can drive the development of cutting-edge therapies from IND through to regulatory approval.
Travel Percent Less than 10%
Functions
Medical Care/Hospital Administration
About the Company
Excelling biotechnology (BioTech) company
Industry Biotechnology
Type Privately Held
About the Role
The Company is in search of a Chief Medical Officer (CMO) to spearhead the clinical and regulatory strategy for its innovative pipeline, with a focus on antibody-drug conjugates in cancer therapeutics. The successful candidate will be responsible for defining and overseeing the clinical development strategy, leading all IND, CTA, and regulatory filings, and directing Phase I-III clinical trials to ensure scientific and operational excellence. This role also involves close collaboration with R&D and translational medicine teams to optimize biomarker-driven trial design, as well as representing the company at various industry events. The CMO will play a key role in partnering with business development and commercial teams on strategic partnerships and future market planning.
Applicants for the CMO position at the company should hold an MD or MD/PhD with a minimum of 10 years' experience in clinical development, particularly in the field of oncology. A strong background in oncology drug development, including experience with bispecifics, T-cell engagers, and immune modulators, is essential. The ideal candidate will have a proven track record of advancing oncology assets from early-phase trials through regulatory approval and possess strong experience in regulatory interactions with global health authorities. The role requires the ability to thrive in a high-growth, VC-backed biotech environment and demands a leader who can drive the development of cutting-edge therapies from IND through to regulatory approval.
Travel Percent Less than 10%
Functions
Medical Care/Hospital Administration